Genome variation of human papillomavirus types: Phylogenetic and medical implications

International Journal of Cancer

Volumn 118, Issue 5, 2006, Pages 1071-1076

  Bernard, Hans Ulrich ^a   Calleja Macias, Itzel E ^a   Dunn, S Terence ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Epidemiology; Etiology; Evolution; Papillomavirus

Indexed keywords

VIRUS PROTEIN;

ANOGENITAL CANCER; ANUS CANCER; CONDYLOMA; ETHNIC GROUP; EVOLUTION; GENETIC VARIABILITY; GENITAL TRACT CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; IMMIGRANT; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SHORT SURVEY; VERRUCA VULGARIS; VIRUS GENOME; WART VIRUS;

ANIMALS; GENOME, VIRAL; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; VARIATION (GENETICS);

EID: 31844436239     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21655     Document Type: Short Survey

References (72)

1. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990;110:1001-20.
2. Crow JF. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 2000;1:40-7.
3. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.
4. Chan SY, Bernard HU, Ratterree M, Birkebak TA, Faras AJ, Ostrow RS. Genomic diversity and evolution of papillomaviruses in Rhesus monkeys. J Virol 1997;71:4938-43.
5. Van Ranst M, Fuse A, Fiten P, Beuken E, Pfister H, Burk RD, Opdenakker G. Human papillomavirus type 13 and pigmy chimpanzee papillomavirus type 1: comparison of the genome organization. Virology 1992;190:587-96.
6. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Bauer HM, Peyton C, Wheeler CM. Assessment of known and novel human papillomaviruses by polymerase chain reaction, restriction digest, nucleotide sequence, and phylogenetic algorithms. J Inf Dis 1994;170:1077-85.
7. Van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992;73:2653-60.
8. Deau MC, Favre M, Orth G. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 1991;184:492-503.
9. Calleja-Macias IE, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, Barrera-Saldaña HA, Cubie HA, Villa LL, et al. Papillomavirus subtypes are natural and old taxa: phylogeny of the human papillomavirus (HPV) types 44/55 and 68a/b. J Virol 2005;79:6565-9.
10. Narechania A, Terai M, Burk RD. Overlapping reading frames in closely related human papillomaviruses result in modular rates of selection within E2. J Gen Virol 2005;86:1307-13.
11. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 1991;29:1765-72.
12. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 2005;79:7014-23.
13. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74:11636-41.
14. Antonsson A, Hansson BG. Healthy skin of many species harbors papillomaviruses which are closely related to their human counterparts. J Virol 2002;76:12537-42.
15. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
16. Chan SY, Chew SH, Egawa K, Grussendorf-Conen EI, Honda Y, Ruebben A, Tan KC, Bernard HU. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology 1997;239:296-302.
17. Heinzel PA, Chan SY, Ho L, O'Connor M, Balaram P, Campo MS, Fujinaga K, Kiviat N, Kuypers J, Pfister H, Steinberg BM, Tay SK, et al. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 1995; 33:1746-54.
18. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara P, Labropoulou V, Pfister H, Tay SK, ter Meulen J, Villa LL, Bernard HU. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 1993;67:6424-31.
19. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara P, Labropoulou V, Mitrani-Rosenbaum S, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and movement of ancient human populations. J Virol 1993;67:6413-24.
20. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-72.
21. Arias-Pulido H, Peyton CL, Torrez-Martinez N, Anderson DN, Wheeler CM. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology 2005;338:22-34.
22. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000; 81:2959-68.
23. Franco EL, Villa LL, Rahal P, Ruiz A. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst 1994;86:1558-9.
24. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001; 93:1325-30.
25. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001;93:315-8.
26. Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ, Villarreal L, Bernard HU, Barrera-Saldana HA. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 2004;319:315-23.
27. Stewart AC, Eriksson AM, Manos MM, Munoz N, Bosch FX, Peto J, Wheeler CM. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol 1996;70:3127-36.
28. Prado JC, Calleja-Macias IE, Bernard HU, Kalantari M, Macay SA, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, et al. Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology 2005;340:95-104.
29. Calleja-Macias IE, Kalantari M, Villa LL, Prado JC, Allan B, Williamson AL, Chung LP, Collins RC, Zuna RE, Dunn ST, Chu TY, Cubie HA, et al. Worldwide genomic diversity of the high-risk human papillomaviruses-31, 35, 52, and 58, which are closely related to HPV-16. J Virol 2005;79:13630-40.
30. Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
31. Mayrand MH, Coutlee F, Hankins C, Lapointe N, Forest P, de Ladurantaye M, Roger M. Detection of human papillomavirus type 16 DNA in consecutive genital samples, does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol 2000;38:3388-93.
32. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 1995;172:747-55.
33. Ho L, Tay SK, Chan SY, Bernard HU. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J Infect Dis 1993;168:803-9.
34. Gagnon S, Hankins C, Tremblay C, Fourreaux K, Forest P, Rouah F, Coutlee F. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV seronegative women at risk for HIV infection. J Med Virol 2005;75: 213-21.
35. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
36. Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, et al. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 2005; 97:896-905.
37. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
38. del Refugio Gonzalez-Losa M, Laviada Mier y Teran MA, Puerto-Solis M, Garcia-Carranca A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol 2004;29:95-8.
39. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Hawes SE, Surawicz C, Goldbaum G, Holmes KK, Kiviat NB. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998;58:3839-44.
40. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Nat Cancer Inst 1997;89:796-802.
41. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, Cheung JL, Xu LY, Cheng AF. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 2002;186:696-700.
42. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996;69:364-8.
43. Zehbe I, Voglino G, Wilander E, Delius H, Marongiu A, Edler L, Klimek F, Andersson M, Tommasino M. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factor for cervical cancer development. Cancer Res 2001;61:608-11.
44. Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 1998;78: 166-71.
45. Hu X, Guo Z, Tianyun P, Ponten F, Wilander E, Andersson S, Ponten J. HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients. Int J Cancer 1999;83:34-7.
46. Nindl I, Rindfleisch K, Lotz B, Schneider A, Duerst M. Uniform distribution of HPV-16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 1999;82:203-7.
47. Rajeevan MS, Swan DC, Nisenbaum R, Lee DR, Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Kmak D, Tadros T, Birdsong G, Husain M, et al. Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 2005; 115:114-20.
48. Da Costa MM, Hogeboom CJ, Holly EA, Palefsky J. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 2002;185:1229-37.
49. Etherington IJ, Ellis JR, Luesley DM, Moffitt DD, Young LS. Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol 1999;72:56-9.
50. Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH, Lee HP. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 1997;66:275-81.
51. De Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Fleuren GJ. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer 2005;114:422-5.
52. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 2003;63:7215-20.
53. Lizano M, Berumen J, Guido MC, Casas L, Garcia-Carranca A. Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 1997;89:1227-31.
54. Hecht JL, Kadish AS, Jiang S, Burk R. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 1995;60:369-76.
55. Rose B, Steger G, Dong XP, Thompson C, Cossart Y, Tattersall M, Pfister H. Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. J Gen Virol 1998;79: 1659-63.
56. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005;337:76-84.
57. Hubert WG. Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol 2005;79:5914-22.
58. Kammer C, Tommasino M, Syrjanen S, Delius H, Hebung U, Warthorst U, Pfister H, Zehbe I. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 2002;86:269-73.
59. Park JS, Hwang ES, Lee CJ, Kim CJ, Rha JG, Kim SJ, Namkoong SE, Um SJ. Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol Oncol 1999;74:23-9.
60. Sichero L, Franco EL, Villa LL. Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 2005;191:739-42.
61. Veress G, Szarka K, Dong XP, Gergely L, Pfister H. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 1999;80:1035-43.
62. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 1996;70:6987-93.
63. De la Cruz-Hernandez E, Garcia-Carranca A, Mohar-Betancourt A, Duenas-Gonzalez A, Contreras-Paredes A, Perez-Cardenas E, Herrera-Goepfert R, Lizano-Soberon M. Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol 2005;86:2459-68.
64. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, Krishna S. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol 2004;78:5934-45.
65. Fujinaga Y, Okazawa K, Nishikawa A, Yamakawa Y, Fukushima M, Kato I, Fujinaga K. Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 1994;9:85-92.
66. Eschle D, Durst M, ter Meulen J, Luande J, Eberhardt HC, Pawlita M, Gissmann L. Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol 1992;73: 1829-32.
67. Kim YB, Song YS, Jeon YT, Park JS, Um SJ, Kim JW, Park NH, Kang SB, Lee HP. Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women. Oncol Rep 2005;14:459-64.
68. Cheng G, Icenogle JP, Kirnbauer R, Hubbert NL, St Louis ME, Han C, Svare EI, Kjaer SK, Lowy DR, Schiller JT. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis 1995;172:1584-7.
69. Pastrana DV, Vass WC, Lowy DR, Schiller JT. NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16. Virology 2001;279:361-9.
70. Touze A, El Mehdaoui S, Sizaret PY, Mougin C, Munoz N, Coursaget P. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol 1998;36:2046-51.
71. Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. J Virol 2005;79:6741-50.
72. Yaegashi N, Xi L, Batra M, Galloway DA. Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus types 6 and 16. J Infect Dis 1993;168:743-7.